Fisher & Paykel Healthcare Corp. Ltd. | Ownership
Companies that own Fisher & Paykel Healthcare Corp. Ltd.
Bennelong Australian Equity Partners Pty Ltd.
28,250,795
4.93%
-226,258
9.32%
12/05/2017
Northcape Capital Pty Ltd.
28,174,622
4.92%
0
33.72%
06/23/2017
Guardians of New Zealand Superannuation
15,634,682
2.73%
2,426,735
1.12%
06/30/2017
Fidelity Management & Research Co.
14,939,604
2.61%
68,087
0.02%
07/31/2018
The Vanguard Group, Inc.
14,565,801
2.54%
255,965
0.01%
07/31/2018
Accident Compensation Corp.
13,918,732
2.43%
-3,737,523
5.88%
04/30/2018
Capital Research & Management Co. (World Investors)
11,833,680
2.06%
577,000
0.02%
06/30/2018
BlackRock Fund Advisors
9,414,161
1.64%
12,360
0.01%
09/06/2018
T. Rowe Price International Ltd.
6,966,800
1.22%
0
0.14%
06/30/2018
Norges Bank Investment Management
6,957,252
1.22%
313,207
0.01%
12/31/2017
| Address |
15 Maurice Paykel Place
Auckland AU 2013
New Zealand
|
|
Employees
|
- |
| Website |
http://www.fphcare.com |
| Updated |
07/08/2019 |
| Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. |
